Ursa Fund Management, LLC Nrx Pharmaceuticals, Inc. Transaction History

Ursa Fund Management, LLC

  • $75.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$0.51 - $2.42 $7,650 - $36,300
-15,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.45 - $5.04 $36,750 - $75,600
15,000 New
15,000 $37,000

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0
View Full List

About NRX Pharmaceuticals, Inc.

NRXP Quotes by TradingView
  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $102M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Ursa Fund Management, LLC Portfolio

Follow Ursa Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ursa Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ursa Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email